Metabolism of dynorphin A(1-13) |
| |
Authors: | Brugos B Hochhaus G |
| |
Affiliation: | Department of Pharmaceutics, College of Pharmacy, University of Florida, Gainesville 32610, USA. |
| |
Abstract: | Dynorphin A(1-13), a tridecapeptide of the endogenous opioid peptides, has modest effects in reducing mild opiate withdrawal in humans. Previous studies revealed that dynorphin also potentiates the analgesic effect of morphine in morphine-tolerant rats and mice. The therapeutic potential of dynorphin A(1-13) is limited due to extensive metabolism by human metabolic enzymes resulting in an in vivo half-life of less than one minute. Chemical modifications of dynorphin A(1-13), such as N-methylation of Tyr1 and amidation of the C-terminus have been shown to be effective in protecting against the proteolytic enzymes in human plasma. This article is a general review of the metabolism of dynorphin A(1-13) in human plasma and CSF. |
| |
Keywords: | |
本文献已被 PubMed 等数据库收录! |
|